BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patientâs own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
No articles found.
Interpace Diagnostics is focused on developing and commercializing molecular diagn...
Interpace Diagnostics is focused on developing ...
OraSure Technologies is empowering the global community to improve health and well...
OraSure Technologies is empowering the global c...
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, ma...
IRIDEX Corporation was founded in 1989 and is a...
Homology Medicines, Inc. is a genetic medicines company dedicated to transforming ...
Homology Medicines, Inc. is a genetic medicines...
Arcturus Therapeutics is developing portfolio of RNA therapeutics for treatment of...
Arcturus Therapeutics is developing portfolio o...
True Leaf Brands Inc. (âTrue Leafâ or the âCompanyâ) (CSE: MJ) (OTCQX: TRL...
True Leaf Brands Inc. (âTrue Leafâ or the â...
Our 3D Printing software platform enables businesses to produce customized product...
Our 3D Printing software platform enables busin...
Join the National Investor Network and get the latest information with your interests in mind.